Amy Raskopf | VP, IR |
Saundra Pelletier | CEO |
Jay File | CFO |
Ram Selvaraju | H.C. Wainwright |
David Amsellem | Piper Sandler |
Annabel Samimy | Stifel |
Thank you for standing by and welcome to the Evofem Biosciences Third Quarter 2021 Financial Results Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s program is being recorded. And now, I’d like to introduce your host for today’s program, Amy Raskopf, Vice President of Investor Relations.